S&P 500   4,351.66 (+0.50%)
DOW   34,122.13 (+0.15%)
QQQ   361.43 (+1.00%)
AAPL   176.46 (+1.45%)
MSFT   320.45 (+0.29%)
META   302.63 (+2.33%)
GOOGL   131.68 (+0.95%)
AMZN   131.60 (+1.76%)
TSLA   255.13 (-0.22%)
NVDA   419.96 (+2.39%)
NIO   8.57 (+1.42%)
BABA   88.16 (+4.82%)
AMD   98.04 (+2.01%)
T   15.06 (-1.63%)
F   12.54 (+2.79%)
MU   69.21 (+1.93%)
CGC   0.82 (+7.14%)
GE   112.91 (-0.07%)
DIS   82.18 (-0.66%)
AMC   7.94 (+3.12%)
PFE   32.78 (-0.21%)
PYPL   58.80 (+0.31%)
NFLX   383.73 (-0.11%)
S&P 500   4,351.66 (+0.50%)
DOW   34,122.13 (+0.15%)
QQQ   361.43 (+1.00%)
AAPL   176.46 (+1.45%)
MSFT   320.45 (+0.29%)
META   302.63 (+2.33%)
GOOGL   131.68 (+0.95%)
AMZN   131.60 (+1.76%)
TSLA   255.13 (-0.22%)
NVDA   419.96 (+2.39%)
NIO   8.57 (+1.42%)
BABA   88.16 (+4.82%)
AMD   98.04 (+2.01%)
T   15.06 (-1.63%)
F   12.54 (+2.79%)
MU   69.21 (+1.93%)
CGC   0.82 (+7.14%)
GE   112.91 (-0.07%)
DIS   82.18 (-0.66%)
AMC   7.94 (+3.12%)
PFE   32.78 (-0.21%)
PYPL   58.80 (+0.31%)
NFLX   383.73 (-0.11%)
S&P 500   4,351.66 (+0.50%)
DOW   34,122.13 (+0.15%)
QQQ   361.43 (+1.00%)
AAPL   176.46 (+1.45%)
MSFT   320.45 (+0.29%)
META   302.63 (+2.33%)
GOOGL   131.68 (+0.95%)
AMZN   131.60 (+1.76%)
TSLA   255.13 (-0.22%)
NVDA   419.96 (+2.39%)
NIO   8.57 (+1.42%)
BABA   88.16 (+4.82%)
AMD   98.04 (+2.01%)
T   15.06 (-1.63%)
F   12.54 (+2.79%)
MU   69.21 (+1.93%)
CGC   0.82 (+7.14%)
GE   112.91 (-0.07%)
DIS   82.18 (-0.66%)
AMC   7.94 (+3.12%)
PFE   32.78 (-0.21%)
PYPL   58.80 (+0.31%)
NFLX   383.73 (-0.11%)
S&P 500   4,351.66 (+0.50%)
DOW   34,122.13 (+0.15%)
QQQ   361.43 (+1.00%)
AAPL   176.46 (+1.45%)
MSFT   320.45 (+0.29%)
META   302.63 (+2.33%)
GOOGL   131.68 (+0.95%)
AMZN   131.60 (+1.76%)
TSLA   255.13 (-0.22%)
NVDA   419.96 (+2.39%)
NIO   8.57 (+1.42%)
BABA   88.16 (+4.82%)
AMD   98.04 (+2.01%)
T   15.06 (-1.63%)
F   12.54 (+2.79%)
MU   69.21 (+1.93%)
CGC   0.82 (+7.14%)
GE   112.91 (-0.07%)
DIS   82.18 (-0.66%)
AMC   7.94 (+3.12%)
PFE   32.78 (-0.21%)
PYPL   58.80 (+0.31%)
NFLX   383.73 (-0.11%)
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Forecast, Price & News

$8.57
-0.09 (-1.04%)
(As of 11:39 AM ET)
Compare
Today's Range
$8.41
$8.77
50-Day Range
$8.66
$14.77
52-Week Range
$8.41
$23.30
Volume
438,910 shs
Average Volume
1.28 million shs
Market Capitalization
$1.17 billion
P/E Ratio
71.42
Dividend Yield
N/A
Price Target
$19.03

AdaptHealth MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
119.8% Upside
$19.03 Price Target
Short Interest
Healthy
7.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.10mentions of AdaptHealth in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$4.10 M Sold Last Quarter
Proj. Earnings Growth
28.57%
From $0.63 to $0.81 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.38 out of 5 stars

Medical Sector

4th out of 965 stocks

Home Health Care Services Industry

1st out of 7 stocks


AHCO stock logo

About AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AHCO Price History

AHCO Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
AdaptHealth (NASDAQ: AHCO)
Why AdaptHealth Stock Dropped Today
What's Going On With AdaptHealth Stock Today?
Stifel Nicolaus Keeps Their Hold Rating on AdaptHealth (AHCO)
Robert W. Baird Keeps Their Buy Rating on AdaptHealth (AHCO)
AdaptHealth Shares Rise on Revenue Beat
Analyst Ratings for AdaptHealth
Jefferies Keeps Their Buy Rating on AdaptHealth (AHCO)
See More Headlines
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

AHCO Company Calendar

Last Earnings
8/08/2023
Today
9/22/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.92
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+122.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$69.32 million
Pretax Margin
2.00%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$2.97 per share
Book Value
$16.01 per share

Miscellaneous

Free Float
117,596,000
Market Cap
$1.16 billion
Optionable
Not Optionable
Beta
0.71
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Richard Alan Barasch (Age 69)
    Interim CEO & Chairman
    Comp: $102.5k
  • Mr. Joshua Parnes (Age 44)
    Pres & Director
    Comp: $1.04M
  • Mr. Jason A. Clemens C.F.A.Mr. Jason A. Clemens C.F.A. (Age 44)
    Chief Financial Officer
    Comp: $870.2k
  • Mr. Albert A. Prast (Age 63)
    Chief Technology Officer
    Comp: $738.03k
  • Mr. Christopher J. Joyce (Age 59)
    Sec.
    Comp: $790.71k
  • Mr. Shaw A. RietkerkMr. Shaw A. Rietkerk (Age 48)
    Chief Operating Officer
  • Ms. Christine Archbold (Age 48)
    Chief Accounting Officer
  • Anton Hie
    VP of Investor Relations
  • Ms. Wendy Russalesi
    Chief Compliance Officer
  • Ms. Leila Vargas
    Exec. VP of Sales & Marketing













AHCO Stock - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AHCO shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price forecast for 2023?

7 equities research analysts have issued 1 year price targets for AdaptHealth's stock. Their AHCO share price forecasts range from $11.00 to $30.00. On average, they anticipate the company's stock price to reach $18.92 in the next twelve months. This suggests a possible upside of 121.3% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2023?

AdaptHealth's stock was trading at $19.22 at the start of the year. Since then, AHCO stock has decreased by 55.5% and is now trading at $8.55.
View the best growth stocks for 2023 here
.

Are investors shorting AdaptHealth?

AdaptHealth saw a drop in short interest in August. As of August 31st, there was short interest totaling 6,090,000 shares, a drop of 14.8% from the August 15th total of 7,150,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 4.5 days. Approximately 7.2% of the company's shares are sold short.
View AdaptHealth's Short Interest
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our AHCO earnings forecast
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) released its quarterly earnings data on Tuesday, August, 8th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. The firm earned $793.29 million during the quarter, compared to analyst estimates of $765.69 million. AdaptHealth had a trailing twelve-month return on equity of 3.03% and a net margin of 1.41%.

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.16 billion-$3.20 billion, compared to the consensus revenue estimate of $3.14 billion.

What other stocks do shareholders of AdaptHealth own?
What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (8.65%), Truist Financial Corp (2.91%), Reinhart Partners LLC. (2.27%), Rubric Capital Management LP (2.15%), State Street Corp (2.04%) and Silvercrest Asset Management Group LLC (1.28%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $8.55.

How much money does AdaptHealth make?

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $1.16 billion and generates $2.97 billion in revenue each year. The company earns $69.32 million in net income (profit) each year or $0.12 on an earnings per share basis.

How many employees does AdaptHealth have?

The company employs 10,900 workers across the globe.

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.

This page (NASDAQ:AHCO) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -